Evidence map›Paper›PMID 30486347›Full record

ArticleMolecules (Basel, Switzerland)2018

Metabolomic Study to Determine the Mechanism Underlying the Effects of

Xiu-Hui Ke, Chun-Guo Wang, Wei-Zao Luo, Jing Wang, Bing Li, Jun-Ping Lv, Rui-Juan Dong, Dong-Yu Ge, Yue Han, Ya-Jie Yang and 4 more

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Frontiers in pharmacology · 2025
    Article
  2. Article
  3. Article
  4. Review
  5. Molecules (Basel, Switzerland) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Xiu-Hui KeSchool of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100102, China. 18910167771@163.com.
Chun-Guo WangBeijing Research Institute of Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China. wangcg1119@126.com.ORCID 0000-0002-2711-1144
Wei-Zao LuoChongqing Academy of Chinese Materia Medica, Chongqing 400065, China. loweizao@163.com.
Jing WangSchool of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100102, China. wangjingyhc@126.com.
Bing LiSchool of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100102, China. dearlvwei@163.com.
Jun-Ping LvBeijing Institute of Biomedicine, Beijing 100091, China. lvjp@chinabib.cn.
Rui-Juan DongSchool of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100102, China. drjdongruijuan@126.com.
Dong-Yu GeSchool of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100102, China. dongyuge@163.com.
Yue HanSchool of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100102, China. han.yue123@163.com.
Ya-Jie YangSchool of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100102, China. yangyajie9511@163.com.
Re-Yila Tu-ErxunSchool of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100102, China. reyilaaa@163.com.
Hong-Shuang LiuSchool of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100102, China. 18811479932@163.com.
Yi-Chen WangSchool of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100102, China. yswangyichen@163.com.
Yan LiaoSchool of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100102, China. liaoyanbucm@163.com.ORCID 0000-0002-5684-0338
Beijing University of Chinese Medicine · CNChongqing Academy of Chinese Materia Medica · CN

Funding

The National Natural Science Foundation of China 81503633 ; 81703744
6 · The paper itself

Abstract

In this study, a non-targeted metabolic profiling method based on ultra-performance liquid chromatography-high resolution mass spectrometry (UPLC-HRMS) was used to characterize the plasma metabolic profile associated with the protective effects of the

Indexed as

Chemical and Drug Induced Liver InjuryAnimalsIsoniazidMetabolomeMetabolomicsMiceMice, Inbred BALB CPolysaccharidesRifampinSagittariaIsoniazidPolysaccharidesRifampinisoniazidliver injuryrifampicinSagittaria sagittifolia polysaccharideultra-performance liquid chromatography-high resolution mass spectrometry (UPLC-HRMS)

Identifiers

PMID30486347
PMCPMC6321494
OpenAlexW2902463507

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.